Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Asana
ASAN
$1.58B
| $189K | ﹤0.01% |
+14,179
| New | +$200K |
|
3127
FuelCell Energy
FCEL
$1.7B
| $188K | ﹤0.01% |
24,138
-1,399
| -5% | -$7.61K |
|
3128
Rapid Micro Biosystems
RPID
$99.1M
| $186K | ﹤0.01% |
55,642
+15,255
| +38% | +$48.3K |
|
3129
AlTi Global
ALTI
$378M
| $186K | ﹤0.01% |
52,162
+13,514
| +35% | +$56.1K |
|
3130
Larimar Therapeutics
LRMR
$416M
| $182K | ﹤0.01% |
56,257
+24,903
| +79% | +$93.4K |
|
|
BRAG
3131
Bragg Gaming Group
BRAG
$43M
| $180K | ﹤0.01% |
59,169
-12,688
| -18% | -$44.8K |
|
3132
Broadway Financial
BYFC
$94.9M
| $179K | ﹤0.01% |
24,760
+97
| +0.4% | +$746 |
|
3133
Nortech Systems
NSYS
$39.8M
| $178K | ﹤0.01% |
19,324
-1,772
| -8% | -$15.8K |
|
3134
Lantern Pharma
LTRN
$35.1M
| $175K | ﹤0.01% |
40,144
-796
| -2% | -$3.32K |
|
3135
Sagimet Biosciences
SGMT
$437M
| $174K | ﹤0.01% |
25,334
| – | – |
|
3136
SkinHealth Systems
SKIN
$94.9M
| $173K | ﹤0.01% |
87,024
-1,996
| -2% | -$4.05K |
|
3137
Clear Channel Outdoor Holdings
CCO
$1.23B
| $172K | ﹤0.01% |
108,966
| – | – |
|
3138
Reading International Class A
RDI
$32.9M
| $172K | ﹤0.01% |
116,901
-66,692
| -36% | -$94.3K |
|
3139
Sutro Biopharma
STRO
$379M
| $172K | ﹤0.01% |
19,752
-43,095
| -69% | -$367K |
|
3140
Siebert Financial
SIEB
$68M
| $171K | ﹤0.01% |
58,709
+28,013
| +91% | +$96.6K |
|
3141
XBiotech
XBIT
$69.2M
| $171K | ﹤0.01% |
64,316
-6,649
| -9% | -$19.7K |
|
3142
Harte-Hanks
HHS
| $171K | ﹤0.01% |
45,988
| – | – |
|
3143
Laird Superfood
LSF
$46.2M
| $170K | ﹤0.01% |
30,476
-2,894
| -9% | -$18.2K |
|
3144
Achieve Life Sciences
ACHV
$626M
| $165K | ﹤0.01% |
+52,420
| New | +$144K |
|
3145
Fuel Tech
FTEK
$48M
| $163K | ﹤0.01% |
+54,401
| New | +$158K |
|
3146
Data Storage Corp
DTST
$7.29M
| $162K | ﹤0.01% |
37,574
+4,920
| +15% | +$21.9K |
|
3147
Forte Biosciences
FBRX
$1.12B
| $161K | ﹤0.01% |
+10,765
| New | +$124K |
|
3148
TScan Therapeutics
TCRX
$51.9M
| $159K | ﹤0.01% |
87,316
-42,540
| -33% | -$75.4K |
|
3149
Marchex
MCHX
$79.7M
| $157K | ﹤0.01% |
87,848
-13,939
| -14% | -$27.6K |
|
3150
Rocky Mountain Chocolate Factory
RMCF
$8.53M
| $157K | ﹤0.01% |
98,796
-2,530
| -2% | -$4.13K |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.